Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

作者： Ruonan Cao*1, Nancy T. Li*2, Chantelle B. Shing1, Zoe Kutulakos3, Cassidy M. Tan2, Alison P. McGuigan1,2 1Institute of Biomedical Engineering,University of Toronto, 2Department of Chemical Engineering and Applied Chemistry,University of Toronto, 3Division of Engineering Science,University of Toronto

简介：

Overview

This protocol documents the fabrication and assembly of SPOT, a high-throughput scaffold-based culture platform, in 96- and 384-well formats. It also details the seeding process for SPOT, both manual and using a commercially available liquid handler.

Key Study Components

Area of Science

• Neuroscience
• Biotechnology
• Drug Screening

Background

• Development of high-throughput platforms for organ cultures.
• Focus on patient-derived organoid cultures.
• Importance of reproducibility in drug screening assays.
• Integration of automated liquid handling technologies.

Purpose of Study

• To improve drug screening assay workflows.
• To facilitate advanced disease modeling.
• To enhance the efficiency of organ-on-a-chip technologies.

Methods Used

• Fabrication of scaffold-based culture platforms.
• Seeding processes for cell cultures.
• Utilization of automated liquid handlers.
• Implementation of hydrogel platforms.

Main Results

• Successful assembly of SPOT platforms in multiple well formats.
• Effective seeding methods demonstrated.
• Improved workflow for drug screening assays.
• Enhanced modeling of patient-derived organ cultures.

Conclusions

• SPOT platforms provide a robust solution for high-throughput screening.
• Automated processes increase reproducibility and efficiency.
• Potential for significant advancements in disease modeling and drug discovery.

Frequently Asked Questions